GSK3: a possible link between beta amyloid peptide and tau protein
- PMID: 19782073
- DOI: 10.1016/j.expneurol.2009.09.011
GSK3: a possible link between beta amyloid peptide and tau protein
Abstract
Tau is a neuronal microtubule-associated phosphoprotein that is highly phosphorylated by glycogen synthase kinase 3 (GSK3). Tau phosphorylation by GSK3 regulates tau binding to microtubules, tau degradation and tau aggregation. Tau phosphorylation is important in Alzheimer disease pathology and in other tauopathies. In Alzheimer disease, it has been proposed that the peptide beta amyloid promotes GSK3 activation, resulting in tau phosphorylation. In this work, we review the links between beta amyloid peptide, tau protein and GSK3 that occur in familial Alzheimer disease. We also discuss the possible links between GSK3 and sporadic Alzheimer disease. Finally, we include a brief review of the pathology of animal models overexpressing GSK3.
Copyright (c) 2009 Elsevier Inc. All rights reserved.
Similar articles
-
Tau phosphorylation and aggregation in Alzheimer's disease pathology.FEBS Lett. 2006 May 22;580(12):2922-7. doi: 10.1016/j.febslet.2006.02.067. Epub 2006 Mar 3. FEBS Lett. 2006. PMID: 16529745 Review.
-
The role of GSK3 in Alzheimer disease.Brain Res Bull. 2009 Oct 28;80(4-5):248-50. doi: 10.1016/j.brainresbull.2009.05.017. Epub 2009 May 27. Brain Res Bull. 2009. PMID: 19477245 Review.
-
Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?Genes Brain Behav. 2008 Feb;7 Suppl 1:57-66. doi: 10.1111/j.1601-183X.2007.00376.x. Genes Brain Behav. 2008. PMID: 18184370 Review.
-
Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.Brain. 2006 Nov;129(Pt 11):3020-34. doi: 10.1093/brain/awl255. Epub 2006 Sep 20. Brain. 2006. PMID: 16987932
-
Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.Brain. 2009 May;132(Pt 5):1335-45. doi: 10.1093/brain/awp023. Epub 2009 Feb 27. Brain. 2009. PMID: 19251756
Cited by
-
In silico anti-alzheimer study of phytochemicals from Lamiaceae family through GSK3-β inhibition.Sci Rep. 2024 Jan 8;14(1):834. doi: 10.1038/s41598-023-47069-w. Sci Rep. 2024. PMID: 38191548 Free PMC article.
-
Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer's Disease.Mol Neurobiol. 2023 Dec 8. doi: 10.1007/s12035-023-03839-1. Online ahead of print. Mol Neurobiol. 2023. PMID: 38064104 Review.
-
Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer's Disease.Adv Pharm Bull. 2023 Nov;13(4):688-700. doi: 10.34172/apb.2023.071. Epub 2023 Jan 23. Adv Pharm Bull. 2023. PMID: 38022801 Free PMC article. Review.
-
The Adult Neurogenesis Theory of Alzheimer's Disease.J Alzheimers Dis. 2023;93(4):1237-1276. doi: 10.3233/JAD-221279. J Alzheimers Dis. 2023. PMID: 37182879 Free PMC article.
-
Neuroprotective Role of DPP-4 Inhibitor Linagliptin Against Neurodegeneration, Neuronal Insulin Resistance and Neuroinflammation Induced by Intracerebroventricular Streptozotocin in Rat Model of Alzheimer's Disease.Neurochem Res. 2023 Sep;48(9):2714-2730. doi: 10.1007/s11064-023-03924-w. Epub 2023 Apr 20. Neurochem Res. 2023. PMID: 37079222
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
